Supraventricular Arrhythmia
8
3
3
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
38%
3 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (8)
Comparison of Single-syringe vs. Double-syringe Techniques for Adenosine Administration in PSVT
Rate, Rhythm or Risk Control for New-onset Supraventricular Arrhythmia During Septic Shock: a Randomized Controlled Trial
Implanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase Inhibitors
Atropine vs Isoprenaline in the Invasive Diagnosis of Arrhythmias
Non-invasive Differentiation of Supraventricular Tachyarrhythmia
Left Atrial Strain and Supraventricular Arrhythmia Burden in Cardiac Light Chain Amyloidosis Following Chemotherapy
Propafenone Versus Amiodarone in Septic Shock
Safety Assessment for Sotalol Protocol in Outpatient Unit